<p>Data are shown for both pMos{tuba::egfp}<sup>frkt707</sup> and pMos{r-opsin::egfp}<sup>frkt890</sup> injections. Injected zygotes (left column) were raised to mature animals (G<sub>0</sub>; middle column), and EGFP expression in the offspring (G<sub>1</sub>; right column) was monitored. Survival rate and transgenic founder rate are given as percentage of injected animals and mature animals, respectively.</p